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ABSTRACT
Abasic (AP) sites are formed spontaneously and are
inevitably intermediates during base excision repair
of DNA base damages. AP sites are both mutagenic
and cytotoxic and key enzymes for their removal are
AP endonucleases. However, AP endonuclease in-
dependent repair initiated by DNA glycosylases
performing b,d-elimination cleavage of the AP sites
has been described in mammalian cells. Here,
we describe another AP endonuclease independent
repair pathway for removal of AP sites in
Schizosaccharomyces pombe that is initiated by a
bifunctional DNA glycosylase, Nth1 and followed
by cleavage of the baseless sugar residue by
tyrosyl phosphodiesterase Tdp1. We propose that
repair is completed by the action of a polynucleotide
kinase, a DNA polymerase and finally a DNA ligase
to seal the gap. A fission yeast double mutant of the
major AP endonuclease Apn2 and Tdp1 shows syn-
ergistic increase in MMS sensitivity, substantiating
that Apn2 and Tdp1 process the same substrate.
These results add new knowledge to the complex
cellular response to AP sites, which could be ex-
ploited in chemotherapy where synthetic lethality
is a key strategy of treatment.
INTRODUCTION
One of the most frequent lesions in DNA is an abasic (AP)
site, generated spontaneously by hydrolysis of the
N-glycosylic bond between the base and the deoxyribose
or as an intermediate in base excision repair (BER) by
monofunctional DNA glycosylases removing damaged
bases (1,2). More than 10000 AP sites are estimated to
arise spontaneously per mammalian cell per day (3). AP
sites are cytotoxic to the cell by blocking DNA replication
and transcription (4), and also mutagenic as bypass of AP
sites by translesion polymerases can result in base substi-
tutions and frameshift mutations (5). To maintain
genomic integrity, the AP sites need to be repaired, and
the main system for their removal is the BER pathway.
The major enzymes for incision of AP sites are AP
endonucleases initiating BER by hydrolyzing the DNA
at the 50 side of the AP site leaving a single-stranded (ss)
nick with 30-hydroxyl (30-OH) and 50-deoxyribose phos-
phate (50-dRP) ends (6). Further repair may follow by
two different pathways. In short patch BER, the 50-dRP
terminus is processed to a 50-phosphate (50-P) by the 50 AP
lyase activity of DNA polymerase b(POLb) (7). In long
patch BER, ﬂap endonuclease (FEN1) removes 2–8nt
from the 50-dRP terminus generated by AP endonuclease
incision, leaving a gap in the DNA (8,9). Bifunctional AP
lyases/DNA glycosylases may also initiate short patch
BER of AP sites. AP lyases cleave the DNA strand at
the 30 side of the AP site by b-elimination generating a
50-P and a 30-a,b-unsaturated aldehyde termini
(30-deoxyribose phosphate; 30-dRP) (10). The 30-dRP
residue is further processed by an AP endonuclease
leaving a 30-OH terminus. Some AP lyases like
Escherichia coli formamidopyrimidine DNA glycosylase
(Fpg) and mammalian endonuclease VIII like DNA
glycosylases 1 and 2 (NEIL1/2) also possess a
d-elimination reaction resulting in 50-P and 30-phosphate
(30-P) termini (11–13). The blocking 30-P is removed by the
phosphatase activity of polynucleotide kinase (PNKP)
(14,15). In this situation, the repair is independent of AP
endonucleases (16). Repair is completed by extension of
the 30-OH terminus by a DNA polymerase and gap sealing
by a DNA ligase (17,18).
The same BER enzymes are also involved in the repair
of DNA single-strand breaks. When resulting from free
radical reaction of deoxyribose residues, such breaks in-
variably possess blocked termini that must be restored to
the conventional 30-OH and 50-P moieties in order for gap
ﬁlling and subsequent ligation to occur. For 50 blocked
termini POLb (AP lyase) and FEN1, in addition to
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30-ends, the key enzymes are AP endonuclease 1 (APE1)
and PNKP together with tyrosyl phosphodiesterase 1,
TDP1. The primary substrate for TDP1 is the product
of abortive topoisomerase 1 (TOP1) reaction, namely,
TOP1 covalently linked to the 30-terminus of DNA
(19–21). Tdp1 was ﬁrst discovered in Saccharomyces
cerevisiae (22) and was shown to hydrolyze the
30-phosphotyrosyl bond between Top1 and DNA
(23–25). The phosphodiesterase activity of TDP1 has
also been implicated in the repair of other 30-end alter-
ations (26), including 30-phosphoglycolates (27). The
TDP1 reaction on these substrates leaves a 30-P similar
to the d-elimination reaction product generated by Fpg/
Nei like DNA glycosylases.
In Schizosaccharomyces pombe, Endonuclease III
(Nth1) is known to be the major AP site incision
enzyme, initiating the cleavage of AP sites by
b-elimination (28,29). The 30-dRP generated is further
processed by the phosphodiesterase activity of the AP
endonuclease Apn2 (28–31). In contrast to AP endonucle-
ases in other eukaryotes and bacteria, the predominant
function of the major AP endonuclease in S. pombe,
Apn2 (30,31), is believed to be in the removal of 30
blocks induced by Nth1 rather than incision of AP sites.
Further, Nth1 is the only identiﬁed DNA glycosylase with
AP lyase activity in S. pombe. No enzyme possessing
b,d-elimination activity like E. coli Fpg and Nei and
human NEIL enzymes has been identiﬁed by sequence
homology searches of the S. pombe genome (32).
However, observation of a faint band migrating like a
d-elimination cleavage product (30-P) has been reported
in activity assays with an AP substrate and S. pombe
wild-type extract (28,33), indicating the presence of an
enzyme with d-lyase activity in S. pombe.
In this study, we describe an AP endonuclease inde-
pendent pathway for repair of AP sites in S. pombe.
Nth1 initiates the repair by b-elimination of the AP site,
whereas Tdp1 cleaves the 30-dRP to generate a 30-P that
can be further processed by phosphatases. This newly
identiﬁed branch of the BER pathway with Tdp1
working downstream of Nth1, seems to function as an
important backup repair pathway in the absence of
Apn2 in the repair of AP sites in S. pombe.
MATERIALS AND METHODS
Strains and media
The S. pombe strains used in this study are derivatives of
the wild-type strains FY526 h
+ and FY527 h
  and are
outlined in Table 1. The strains were grown in complete
yeast extract medium supplemented with 200mg/l
adenine, uracil, leucine, histidine, arginine and lysine
(YES). When selection was required, pombe minimal glu-
tamate (PMG) medium containing appropriate supple-
ments, was used. To generate a mutant containing the
kanMX cassette, the transformed cells were incubated in
minimal sporulation liquid (MSL) medium (34) to give the
marker time to be expressed, before the cells were
challenged with geneticin. Escherichia coli BL21 Codon
Plus (DE3) RIL cells (Stratagene) were used for expression
and puriﬁcation of recombinant Tdp1. The E. coli cells
were grown in Luria–Bertani (LB) medium with antibiotic
selection.
Schizosaccharomyces pombe cell-free extracts
Schizosaccharomyces pombe cells were grown in YES at
30 Ct oa nO D 600 of 1.5–2.0. The cells were harvested by
centrifugation, washed with water, resuspended in extract
buffer (25mM HEPES pH 7.4, 0.1mM EDTA, 100mM
KCl, 2mM DTT and protease inhibitor cocktail) (Merck,
Calbiochem) and frozen at  80 C. The cell-extract buffer
suspension was thawed, glass beads added and the cells
disrupted by the use of a Beadbeater for 1min 7, with
1min incubation on ice in between. Cell debris was
removed from the lysate by centrifugation at 12000rpm
for 30min at 4 C. The protein concentration was
determined by the Bradford method using bovine serum
albumin as reference.
Puriﬁcation and identiﬁcation of endogenous Tdp1
Cell-free extract from 60l of S. pombe RHP357 (nth1
 )
cells was run through seven different columns in the fol-
lowing order; SP Sepharose Fast Flow 20ml, Resource Q
6ml, Heparin 2ml, Resource S 1ml, Hydroxyapatite
20ml, MonoS SMART and Superdex75 SMART. From
all of the columns except hydroxyapatite, proteins were
eluted with a linear gradient of 0.05–1M NaCl in
HEPES buffer [25mM HEPES pH 7.4, 50mM NaCl,
10mM b-mercaptoethanol (ME)]. For the hydroxyapatite
column, proteins were eluted with a linear gradient of
0–400mM KHPO4 pH 7.4 in HEPES buffer. After each
column, the fractions were analyzed for 30-deoxyribose
(30-dR) removing activity. Active fractions were pooled,
dialyzed with HEPES buffer and loaded on the next
column. After the ﬁnal column, the proteins in the frac-
tions ﬂanking the activity peak were separated by 10%
SDS–PAGE. The gel was stained with Imperial Protein
Stain (Thermo Fischer), and visible bands in the most
active fraction were cut from the gel, digested and
analyzed by mass spectrometry (MS).
Disruption of nth1 and apn2
An nth1::ura4
+ mutant (RHP357) and an apn2::kanMX
mutant (RHP302) were generated by gene disruption of
the nth1 or apn2 wild-type allele in FY526 (wt) or FY527
(wt) respectively as described (28,35). An nth1
 apn2
 
double mutant (RHP383) was generated by random
spore analysis by crossing RHP357 and RHP302.
Genotypes of the mutants were conﬁrmed by colony
PCR. Four to six different isolates were screened for
methyl methanesulfonate (MMS) sensitivity and for some
mutants also camptothecin (CPT) sensitivity. A represen-
tative isolate was used in further crosses or survival assays.
Cloning and disruption of tdp1
The tdp1 gene (without start codon) was ampliﬁed by
PCR of S. pombe genomic DNA using the primers
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attgggaggccaaac and cloned into the BamHI and XhoI
sites of pET28b (Novagen). The resulting expression con-
struct (pET28b-Tdp1) has a 6 His tag in frame with the
N terminus of Tdp1. Correct sequence of pET28b-Tdp1
was veriﬁed by DNA sequencing.
To generate a tdp1 disruption construct, 930 bases of
the tdp1 gene were removed by cleaving the pET28b-Tdp1
construct with BsrG1 and SpeI, and replacing it with the
kanMX cassette PCR ampliﬁed from the pCore vector
using primers 50-cgtatgtacaccagtcgggaaacctgtcgt and
50-cgcaactagtcatcgatgaattcgagctcgtt. The resulting con-
struct contained 330 and 350bp (up and downstream,
respectively) of the tdp1 gene that ﬂanks the kanMX
cassette. For targeted gene disruption, the tdp1::kanMX
fragment was PCR ampliﬁed by using the primers 50-cgat-
ggatccgtctactcttgagcccgaaa and 50-cgtactcgagttaccaattggg
aggccaaac. The ends were partly degraded with Bal31
nuclease and this tdp1::kanMX fragment was used for
transformation of S. pombe RHP357 (nth1
 ) cells using
the S.c. Easy Comp Transformation kit (Invitrogen).
The transformed cells were incubated in MSL medium
at 30 C for 16h and plated on YES with 100mg/l G418.
The resulting tdp1
 nth1
  double mutant strain was
designated RHP378. A tdp1
  single mutant (RHP379),
tdp1
 apn2
  double mutant (RHP382) and
tdp1
 apn2
 nth1
  triple mutant (RHP381) were con-
structed by random spore analysis after mating of
RHP378 and FY527 to yield a tdp1
  single mutant
(RHP379) and mating of RHP378 and RHP302 to yield
tdp1
 apn2
  (RHP382) and tdp1
 apn2
 nth1
  (RHP381).
Genotypes of the mutants were veriﬁed and a representa-
tive isolate selected as described earlier.
Tdp1 expression and puriﬁcation
Escherichia coli BL21 Codon Plus (DE3) RIL cells trans-
formed with pET28b-Tdp1 were grown in LB medium
with 50mg/ml kanamycin at 37 Ct oa nO D 600 of  0.8.
Protein expression was induced with 1mM IPTG and cells
grown for 2h. The cells were harvested by centrifugation,
washed with water and frozen at  80 C. The cell pellet
was thawed and resuspended in sonication buffer (50mM
Na2HPO4/NaH2PO4 pH 8.0, 300mM NaCl, 10mM ME),
and the cells were broken by sonication. Cell debris was
removed from the lysate by centrifugation at 13000rpm
for 20min at 4 C. The protein extract was loaded on to a
Ni-NTA Agarose column (Qiagen) equilibrated with son-
ication buffer. The column was washed with sonication
buffer with 50mM imidazole, and the Tdp1 protein was
eluted by increasing the imidazole concentration to
300mM. Partially puriﬁed protein was visualized by sep-
aration on a 10% SDS–PAGE and Coomasie blue
staining. Fractions containing Tdp1 were pooled,
dialyzed with HEPES buffer and further puriﬁed on a
Resource S 1ml and a Superdex75 SMART column
eluting the Tdp1 protein by a linear increase in the NaCl
concentration from 0.05 to 1M in the HEPES buffer.
Fraction 14 from the Superdex75 column was used in
the activity assays.
DNA cleavage activity assays
The sequence of the phosphotyrosine substrate was
50-ctacgtcagatctgaggatg-pTyr, while for the uracil,
8oxoG and 5ohC substrates the sequence was 50-gcatgcct
gcacggXcatggccagatccccgggtaccgag, where X is the
damaged base. The oligonucleotide substrates were
end-labeled using T4 polynucleotide kinase (New
England Biolabs) and [g
32P] ATP (3000Ci/mmol,
Amersham). Double-stranded substrates (ds; U:C,
8oxoG:C and 5ohC:G) were generated by annealing the
labeled oligonucleotide to a complementary strand. To
generate intact AP substrate or a nicked AP substrate
with a 30-dRP terminus, the uracil substrate was pre-
treated with uracil DNA glycosylase (Udg, NEB) or
Udg and Nth (NEB), respectively, for 15min at 37 C.
Ten microliters of reaction mixtures contained reaction
buffer (70mM MOPS pH 7.5, 1mM EDTA, 1mM DTT
and 5% glycerol), 10fmol DNA substrate and protein
concentrations as indicated. The reactions were incubated
at 37 C for 30min and stopped by addition of 10ml
formamide loading dye (80% formamide, 10mM
EDTA, 0.1% xylene cyanol and bromphenol blue). To
hydrolyse uncleaved AP sites (in Udg glycosylase assay),
the samples were incubated with 100mM NaOH for
10min at 70 C and subsequently neutralized with
100mM HCl. The reactions were stopped by adding
formamide loading dye. The oligonucleotides were
denaturated at 90 C for 3min, and the reaction products
were separated on a 20% sequencing gel at 40W for 1.5h
in 1  taurine buffer. The radiolabeled fragments were
Table 1. Schizosaccharomyces pombe strains used in this study
Strain name Genotype References
FY526 wt h
+ ade6-M216 ura4-D18 leu1-32 his3-D1 S. Forsburg (55)
FY527 wt h
  ade6-M216 ura4-D18 leu1-32 his3-D1 S. Forsburg (55)
RHP302 h
  apn2::kanMX ade6-M216 ura4-D18 leu1-32 his3-D1 FY527
RHP357 h
+ nth1::ura4
+ ade6-M216 ura4-D18 leu1-32 his3-D1 FY526
RHP378 h
+ tdp1::kanMX nth1::ura4
+ ade6-M216 ura4-D18 leu1-32 his3-D1 RHP357
RHP379 h
? tdp1::kanMX ade6-M216 ura4-D18 leu1-32 his3-D1 RHP378 FY527
RHP381 h
? tdp1::kanMX apn2::kanMX nth1::ura4
+ ade6-M216 ura4-D18 leu1-32 his3-D1 RHP378 RHP302
RHP382 h
? tdp1::kanMX apn2::kanMX ade6-M216 ura4-D18 leu1-32 his3-D1 RHP378 RHP302
RHP383 h
? nth1::ura4
+ apn2::kanMX ade6-M216 ura4-D18 leu1-32 his3-D1 RHP357 RHP302
h
?, mating type not determined; wt, wild-type.
2002 Nucleic Acids Research, 2012,Vol.40, No. 5visualized by using a PhosphorImager (Typhoon 9410
Variable Mode Imager), and ImageQuant TL was used
for quantiﬁcation.
Schizosaccharomyces pombe survival assay
Schizosaccharomyces pombe cells were grown in YES
medium to OD600 0.8, harvested by centrifugation and
resuspended in water. The cells were 10-fold serial diluted
in water and spotted on YES plates containing concentra-
tions of MMS or CPT as indicated. The cells were
incubated at 30 C for 3days.
RESULTS
Identiﬁcation of the d-elimination enzyme in S. pombe
Certain bifunctional DNA glycosylases/AP lyases such as
Fpg and Nei in E. coli and NEIL1 and 2 in mammalian
cells, perform d-elimination cleavage of AP sites. Despite
neither encoding Fpg nor Nei homologs, d-elimination
cleavage (30-P) is evident in protein extracts from S.
pombe wild-type cells (Figure 1A, left panel) (28,33). In
an attempt to identify the responsible enzyme, cell-free
extract from S. pombe RHP357 (nth1
 ) cells was
isolated. The nth1
  strain was used to avoid interference
from Nth1 which also acts on AP sites. When compared to
total protein extract made from wild-type cells, the 30-P
cleavage product of a ds AP substrate was not observed in
nth1
  extracts (Figure 1A, left panel), suggesting that the
enzyme responsible is either dependent on Nth1 to be
active or that the enzyme is only processing the 30-dRP
terminus generated by Nth1 cleavage. When the AP sub-
strate was pretreated with Nth, the 30-P product was re-
covered (Figure 1A, right panel). This Nth-nicked
substrate was used in the subsequent puriﬁcation process.
To identify the enzyme responsible for the
d-elimination, the protein was puriﬁed by following the
30-P cleavage product through a combination of seven dif-
ferent column matrices that separate proteins according to
their size, charge and speciﬁc chemical afﬁnities
(Figure 1B). Proteins in the peak fraction (fraction 13,
Figure 1C) from the last column (Superdex75 SMART)
were separated by SDS–PAGE (Figure 1D) and visible
bands excised from the gel. Analysis by mass spectroscopy
of the marked band ( 60kDa) revealed the identity of
only two proteins; tyrosyl DNA phosphodiesterase 1
(Tdp1) and ATP-dependent RNA helicase (Ded1). Of
these, Tdp1 caught our interest. Schizosaccharomyces
pombe Tdp1 has a molecular mass of 61.5kDa and is
known to process ‘dirty’ 30-ends leaving a terminal phos-
phate like d-lyases, making it a likely candidate. Activity
assays with the partly puriﬁed Tdp1 (fraction 13) showed
d-cleavage activity on 30-dRP termini in a ds context
(Figure 1C) and also on a ss 30-dRP substrate
(Figure 1E). A very weak AP lyase activity toward an
intact ds AP substrate is present in this partly puriﬁed
fraction (Figure 1F).
No d-cleavage of AP sites in protein extracts from
tdp1
  cells
To verify that Tdp1 was responsible for the observed 30-P
cleavage product of the nicked AP substrate, a tdp1
 nth1
 
double mutant (RHP378) was generated. Total protein
extract from RHP378 (tdp1
 nth1
 ) and also RHP357
(nth1
 ) cells were prepared and used in activity assay
with an Nth-nicked ds AP substrate. The result showed
that the 30-P cleavage product was absent in the double
mutant (Figure 2A), conﬁrming that Tdp1 possesses the
major d-elimination activity in S. pombe. To exclude that
the missing 30-P cleavage product was due to an inactive
protein extract, the extracts from both nth1
  and
tdp1
 nth1
  cells were analyzed for an independent DNA
repair activity and a uracil DNA glycosylase (Udg) assay
was performed. Udg is a monofunctional DNA
glycosylase removing uracils from DNA. The two
extracts were near to identical for Udg activity, conﬁrming
that both extracts were functional (Figure 2B).
Recombinant Tdp1 processes 30-a,b-unsaturated aldehydes
To further investigate the role of Tdp1 in processing
30-dRP termini, recombinant S. pombe Tdp1 was
puriﬁed from E. coli. The puriﬁed Tdp1 showed a single
band of  60kDa when analyzed by SDS–PAGE
(Supplementary Figure S1). To exclude interference from
copurifying E. coli enzymes, cleavage of 8oxoG (Fpg) and
5ohC (Nei) substrates were examined. No activity toward
these substrates was observed (Supplementary Figure S2A
and B) with 50-fold more Tdp1 than used to obtain full
cleavage with the nicked AP DNA. The main substrate for
Tdp1 is a phosphotyrosyl moiety at the 30-end of DNA,
and recombinant Tdp1 cleaved such a substrate as
expected (Figure 3A). In addition, Tdp1 showed
d-elimination activity toward both ds and ss AP substrate
pre-treated with Nth (Figure 3B, panels I and II). It has
been reported that human TDP1 has AP lyase activity
toward both ds and ss AP substrates with the ss AP sub-
strate as the preferred one (36). Activity assay with an
intact ss or ds AP substrate revealed that S. pombe Tdp1
did not efﬁciently incise these substrates (Figure 3B,
panels III and IV). Tdp1 cleaved only  3 and 7% of the
intact ds and ss AP substrates, respectively, when using the
same amount of Tdp1 (2ng) that gave full cleavage of
Nth-nicked AP substrates.
During the b-elimination reaction, a covalent imino
enzyme–DNA complex is formed which can be trapped
with sodium borohydride. Trapping assay with ss AP sub-
strate did not reveal any trapped product (data not
shown), conﬁrming that Tdp1 does not possess robust
AP lyase activity.
Tdp1 works in an alternative BER branch in S. pombe
Processing of the 30-dRP terminus generated by Nth1
cleavage of an AP site, suggests a role of Tdp1 in the
BER pathway acting downstream of Nth1. To investigate
this, a tdp1
  single mutant (RHP379) was constructed. In
addition, double and triple mutants of tdp1
  and BER
mutant cells were generated; RHP378 (tdp1
 nth1
 ),
Nucleic Acids Research,2012, Vol.40, No. 5 2003RHP381 (tdp1
 apn2
 nth1
 ) and RHP382 (tdp1
 apn2
 ).
The anticancer drug camptothecin (CPT) acts by
stabilizing Top1–DNA adducts, resulting in strand
breaks in the DNA (37). Tdp1 is shown to be the key
enzyme for removal of such adducts (24,38). When
challenged with CPT, ﬁssion yeast cells lacking Tdp1
became sensitive as previously reported (Figure 4A) (39).
Next, the tdp1
  mutant was exposed to the alkylating
agent MMS that via the Mag1 DNA glycosylase generates
a heavy burden of AP sites. The tdp1
  single mutant
displayed no sensitivity to MMS and the tdp1
 nth1
 
double mutant was as sensitive as the nth1
  single
mutant (Figure 4B). This is in accordance with Nth1
and Tdp1 acting in the same pathway. Further, lack of
sensitization of the nth1
  mutant by deletion of tdp1, con-
ﬁrmed our biochemical data that showed lack of a robust
AP lyase activity of S. pombe Tdp1. In contrast, the
tdp1
 apn2
  double mutant showed a synergistic increase
in MMS sensitivity compared to the respective single
mutants (Figure 4B), suggesting that Tdp1 and Apn2 act
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Figure 1. Identiﬁcation and characterization of endogenous Tdp1. (A) Cleavage of intact and nicked AP substrates in S. pombe whole cell extracts.
Two micrograms of total protein extracts from FY526 (wt) and RHP357 (nth1
 ) cells were incubated with 10fmol 50-[
32P]-labeled duplex DNA
containing an AP site (opposite C) in reaction buffer for 30min at 37 C (left panel). Two micrograms of the RHP357 (nth1
 ) extract was used in an
equivalent reaction using the same substrate pretreated with Nth (right panel). The cleavage products were separated by 20% denaturing PAGE and
visualized by phosphorimaging. The DNA substrates with an intact (S1) or Nth-nicked (S2) AP site and the cleavage products (30-dRP and 30-P) are
indicated. Escherichia coli Nth and Fpg were used as positive controls for migration of the 30-dRP and 30-P products, respectively. (B) Schematic
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and puriﬁed human NEIL1 were used as positive controls for 30-dRP and 30-P, respectively.
2004 Nucleic Acids Research, 2012,Vol.40, No. 5on the same substrate. In absence of both Tdp1 and Apn2,
the 30-blocking lesion (30-dRP) produced by Nth1 is hardly
processed and contributes to the cytotoxicity seen in the
tdp1
 apn2
 mutant after MMS exposure. The importance
of these two genes was also evident under normal condi-
tions as the tdp1
 apn2
  double mutant was more slowly
growing (Figure 4B, left panel). Deletion of nth1 in a
tdp1
 apn2
  background partially relieved the MMS sen-
sitivity of the tdp1
 apn2
  double mutant (Figure 4B). This
is similar to what happens to the apn2
  single mutant
when nth1 is deleted [Figure 4B, and (28)]. This is
probably due to accumulation of 30-blocking lesions
generated by Nth1 that cannot be further processed in
the absence of Apn2 and Tdp1. 30-dRP termini are more
toxic to the cell than intact AP sites, which can be
bypassed by translesions polymerases. The observed
slow growing phenotype of the tdp1
 apn2
  double
mutant in unstressed cells appears to be relieved in the
tdp1
 apn2
 nth1
  triple mutant (Figure 4B, left panel),
demonstrating that Nth1 also acts on endogenously
generated DNA damage.
In summary, our results show that Tdp1 plays a more
general role in DNA repair than only removal of
Top1-mediated DNA damage. Tdp1 can be placed in a
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Nucleic Acids Research,2012, Vol.40, No. 5 2005new branch of the BER pathway (Figure 5) working
downstream of Nth1 by processing the 30-a,b-unsaturated
aldehyde left after Nth1 cleavage. A 30-P terminus is
generated by the Tdp1 reaction and S. pombe Pnk1 has
been reported to have both 50-kinase and 30-phosphatase
activity (40). Pnk1 is thus a likely candidate for processing
of the 30-P terminus to generate a 30-OH. Repair can now
be completed by a DNA polymerase ﬁlling in a new base
and a DNA ligase sealing the nick. The tdp1
  mutant was
not hypersensitive to MMS as observed for the apn2
 
mutant, indicating that the Apn2-dependent pathway is
the preferred one, with Tdp1 working as an important
backup of Apn2 in the repair of AP sites.
DISCUSSION
Abasic sites are one of the most frequent endogenous
lesions in cellular DNA and their repair is critical for
genomic stability and cellular survival. In S. pombe,
Nth1 is the major AP site incision enzyme cleaving the
AP sites by b-elimination. The S. pombe genome does
not encode any bifunctional DNA glycosylases possessing
both b- and d-elimination similarly as E. coli Fpg/Nei and
human NEIL enzymes. However, a cleavage product of an
AP DNA substrate migrating similar as the d-lyase
product (30-P) has been reported in protein extracts from
ﬁssion yeast (28,33). In this work, we have revealed that
S. pombe Tdp1 removes 30-a,b-unsaturated aldehydes and
we address the biological signiﬁcance of Tdp1 in repair of
AP sites.
Tdp1 was ﬁrst isolated in S. cerevisiae by its ability to
hydrolyze the phosphodiester bond between the Top1
tyrosine residue and the DNA 30-phosphate originating
from abortive Top1–DNA complexes. Later on, it has
been shown that human and yeast Tdp1 also process a
variety of other 30-alterations such as phosphoglycolates
(27), tetrahydrofuran (AP site mimic) (26) and
mononucleosides (26), emphasizing the general lack of
speciﬁcity for the 30-leaving group. To this list, we add
30-dRP residues that we show are processed both by en-
dogenous and recombinant S. pombe Tdp1. Recombinant
Tdp1 removed 30-dR residues from ss and ds substrates
equally efﬁciently and at a comparable rate to tyrosyl
residues, the recognized Tdp1 substrate, indicating that
this is a biologically relevant substrate. Further, the
increased alkylation sensitivity of the tdp1
 apn2
  double
mutant supports the idea that Tdp1 plays a signiﬁcant role
in processing of AP sites. Though, detailed kinetic experi-
ments are needed to carefully determine the substrate pref-
erences for Tdp1. Recently, Lebedeva et al. (36) showed
removal of 30-dRPs also by recombinant human TDP1,
however, the in vivo signiﬁcance of this observation was
not addressed. Lebedeva et al. (36) also reports AP lyase
activity for human TDP1. In contrast, S. pombe Tdp1
showed negligible AP lyase activity toward the ss and ds
AP substrates. Deletion of tdp1 in the nth1
  mutant did
not sensitize the nth1
  cells when challenged with MMS,
further supporting that S. pombe Tdp1 is not an AP lyase.
Also S. cerevisiae Tdp1 displayed no cleavage of intact AP
sites (41).
The product of Tdp1 activity is DNA with a 30-P
terminus, which needs to be further processed by a
30-phosphatase to create termini compatible for repair syn-
thesis. In humans, polynucleotide kinase catalyzes
removal of 30-P from DNA ends (15,16,42) and repair of
TOP1–DNA complexes can be reconstituted with TDP1,
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Figure 4. Genetic interactions between tdp1
  and BER mutants. (A) CPT sensitivity in the ﬁssion yeast tdp1
  strain. Exponentially growing
wild-type (FY526) and tdp1
  (RHP379) cells were serial diluted in water and spotted onto YES plates containing CPT as indicated. The plates
were incubated for 3days at 30 C and the survival assessed. (B) MMS survival analysis of the tdp1
  and BER single and double mutants.
Exponentially growing wild-type (FY526), nth1
  (RHP357), apn2
  (RHP302), tdp1
  (RHP379), nth1
 apn2
  (RHP383), tdp1
 nth1
  (RHP378),
tdp1
 apn2
  (RHP382) and tdp1
 apn2
 nth1
  (RHP381) cells were serial diluted in water and spotted onto YES plates containing MMS as indicated.
The plates were incubated for 3days at 30 C and the survival assessed.
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been shown to exist in complex with PNKP (20), suggest-
ing that TDP1 and PNKP function in the same pathway in
human cells. Also in S. cerevisiae, a link between PNKP
and Tdp1 exists as the PNKP homolog Tpp1 is epistatic to
Tdp1 (43). The genome of S. pombe encodes a polynucleo-
tide kinase, Pnk1 showing phosphatase activity (40,44),
and a pnk1
  mutant is CPT sensitive (40), suggesting a
role in repair of Top1–DNA damage. We propose that
Pnk1 in S. pombe is responsible for removal of the 30-P
left after Tdp1 cleavage of 30dRP termini as also suggested
for repair of oxidative stress-induced DNA damage (39).
Further, in human cell-free extracts TDP1 has been
reported to interact with the BER proteins DNA ligase
III and XRCC1 (20,45), and XRCC1 was shown to stimu-
late both 50-kinase and 30-phosphatase activity of PNKP
(46). Overall, these observations suggest a role for TDP1
in an APE1-independent BER pathway in mammals
similar to that for the NEIL proteins (16,47). It is also
tempting to speculate whether Fpg/NEIL enzymes could
act in parallel with Tdp1 in removing 30-tyrosyl residues
from DNA termini. At least for Fpg, this appears not to
be the case, as in our experiments Fpg could process
30-dRPs but not 30-tyrosines (Figure 3A and B).
TDP1 has an essential role in humans as mutation in the
TDP1 gene results in the hereditary disease SCAN1
(spinocerebellar ataxia with axonal neuropathy-1), a de-
generative neurological syndrome speciﬁcally affecting
neurons (48). It is believed that TOP1 single-strand
breaks accumulate in the absence of TDP1 and that
neurons are particularly vulnerable due to high levels of
oxidative stress, low levels of antioxidant enzymes and
high transcriptional activity (20,24). Mammalian cells
lacking TDP1 are consequently hypersensitive to the
TOP1–inhibitor CPT (24). Further, it was shown that
these cells have reduced repair capacity for oxidative
DNA single-strand breaks (20), suggesting that the
repair function of TDP1 is not restricted only to TOP1–
DNA adducts. The S. cerevisiae tdp1 mutant has been
analyzed for sensitivity toward CPT and also agents
inducing oxidative stress. However, unless combined
with other DNA repair defect mutants, little or no
increase in sensitivity is seen, probably reﬂecting redun-
dancy for the repair of these lesions in budding yeast
[CPT: Rad1and Rad9; (49) and Rad9; (25)]. Similarly, in
our study, MMS sensitivity for the tdp1
  mutant was de-
pendent on Apn2. We propose that Apn2 is the preferred
enzyme removing the 30-dRP generated by Nth1, and that
in the absence of Apn2, Tdp1 activity is important.
Similarly, in S. cerevisiae, deletion of apn1 and apn2 in
the tdp1 mutant sensitizes this strain to bleomycin,
possibly indicating overlapping substrate speciﬁcities for
these three enzymes (49). To our knowledge, MMS was
not tested for these mutants. The b-lyase function of Ntg1
and Ntg2 is also important in S. cerevisiae for repair of
MMS-induced damage (50), and also budding yeast lack
DNA glycosylases performing d-elimination. Further
studies are needed to evaluate a role for Tdp1 in process-
ing alkylation-induced DNA damage in other species.
Cells have evolved a complex network of DNA repair
pathways for removal of DNA damage to ensure main-
tenance of genomic integrity. Understanding the roles of
different human or mammalian DNA repair proteins in
such a genetic network is a formidable challenge. This is
partly because genetic studies in mammalian systems have
been limited due to the lack of readily available tools
including deﬁned mutant cell lines, regulatory expression
systems and appropriate selectable markers. To circum-
vent these difﬁculties, model genetic systems in lower
eukaryotes have become an attractive choice. The mech-
anisms of the DNA repair have been largely conserved
from bacteria to mammals both when it comes to structure
and function, making simpler organisms suitable models.
Conclusions derived from genetic and biochemical
analysis in yeast can often directly be extrapolated to
human systems and indeed, results from such studies
have been instrumental for elucidating corresponding
pathways in mammalian cells.
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Figure 5. BER of AP sites in S. pombe. AP sites in S. pombe are
mainly repaired by the short-patch BER pathway (thick arrows),
initiated by incision of the AP site by Nth1, leaving 50-P and 30-dRP
ends. The lethal 30-block is further processed to a 30-OH by the
30-phosphodiester activity of Apn2. A DNA polymerase and a DNA
ligase ﬁnally complete the repair by ﬁlling the gap and sealing the nick.
Alternatively, Apn2 initiates repair by incision of the AP site leaving a
50-dRP end, which can be further processed by long-patch (strand dis-
placement synthesis and subsequent cleavage of the 50-ﬂap by Rad2) or
short-patch BER (gap insertion and 50-dRP lyase by SpPol4). Apn2
participates in both long-patch and short-patch BER. In this study,
we propose an AP endonuclease independent branch of BER in S.
pombe with Tdp1 working as a backup of Apn2 in the repair of
30-dRP termini left after Nth1 cleavage. Pnk1 is suggested to work
downstream of Tdp1 by processing the 30-P generated by Tdp1,
leaving a 30-OH. Finally, repair is completed by a DNA polymerase
and a DNA ligase.
Nucleic Acids Research,2012, Vol.40, No. 5 2007One of the main advantages of using yeast as an experi-
mental system is the ease of generation and characteriza-
tion of double, triple and multiple mutants. Such studies
have revealed that there is signiﬁcant overlap between the
different DNA repair pathways as discussed earlier.
Defects in two or more DNA repair pathways often
result in dramatically increased sensitivity (synthetic le-
thality) toward DNA damaging agents as seen for the
tdp1
 apn2
  double mutant. As cancer cells often are de-
fective or dysregulated in one or more DNA repair
pathways, there is a potential to exploit the ‘synthetic le-
thality’ phenotype in cancer therapy by the use of speciﬁc
inhibitors (51). CPT is in use against certain cancers and
TDP1 is counteracting the CPT effects. Inhibitors of
TDP1 have already been identiﬁed, with the intention to
enhance the activity of anticancer agents like CPT (52). In
human cells, the BER enzyme APE1 is the main enzyme
for cleavage of AP sites, and overexpression of APE1 is
often observed in tumor cells (53). Subsequently, APE1
inhibitors could enhance the effect of chemotherapeutic
agents in APE1 overexpressing tumors (54). By using a
combination of both APE1 and TDP1 inhibitors based
on targeting/inactivating the BER pathways, chemother-
apy may be more successful. Corresponding studies based
on mutant analysis as reported in this study needs to be
executed in mammalian cell lines to conﬁrm the existence
of a similar AP endonuclease independent BER of AP
sites involving TDP1 and PNKP.
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